Tag: renal cancer

Tenofovir disoprovil fumarate HIV prophylaxis linked with minimal kidney impact

Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma

byNeel Mistryand1 others

March 21, 2023

1. Disease-free survival in the placebo group was 50.7 months and was never reached in the intervention group; however, there ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

The 5x-multiplier algorithm reduces opioids prescribed at discharge
Historical redlining associated with lower breast cancer screening across urban neighborhoods
N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration

No Result

View All Result

Tag: renal cancer

Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits